Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease?

Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease?

Introduction: Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by lymph node histopathology and systemic symptoms. To our knowledge, there are no descriptions in the literature of long-term outcomes of human herpesvirus-8 (HHV-8)-associated MCD. Case Description: ...

Full description

Bibliographic Details
Main Authors: Gavin Ha, Kelsey Kwong, Bryce Tanaka, Yoshito Nishimura, Christina Chong
Format: Article
Language:English
Published: SMC MEDIA SRL 2023-06-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
multicentric castleman disease
human immunodeficiency virus
interleukin 6
siltuximab
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3904

Similar Items

Similar Items